-A +A

Infliximab


Trade Names: 
Remicade®

Possible Uses: 
Approved to treat ulcerative colitis and rheumatoid arthritis. Unlabeld use in BMT is for severe GI tract GVHD not controlled by steroids

Special Notes: 
In GVHD treatment the drug can be given weekly for 4-8 weeks

Drug Interactions: 
Avoid echinacea

Possible Side Effects: 
Headache, nausea, diarrhea, stomach pain, infections,high blood pressure, rash, upset stomach, bronchitis, anemia,flushing.
Last updated on 02/01/2010
BMT InfoNet 2310 Skokie Valley Road, Suite 104, Highland Park, IL 60035 • 888.597.7674 • Fax: 847.433.4599 • help@bmtinfonet.org
All Rights Reserved